Chronic Kidney Disease
Conditions
Interventions
None listed
Sponsors
Kyowa Hakko Kirin Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.A broad spectrum of CKD with eGFR of 10-59 mL/min/1.73m2 2.Patients who are not scheduled dialysis initiation. 3.Patients who give a written consent for this study 4.Japanese patients living in Japan
Exclusion criteria
Exclusion criteria: 1.liver cirrhosis 2.HIV/AIDS 3.transplant recipients and patients 4.polycystic kidney disease 5.cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes are progression of CKD defined by reduction in eGFR, CVD events and all cause mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes are QOL and hospitalization. | — |
Countries
Japan
Contacts
Public ContactToru Ushigaki
Kyowa Hakko Kirin Co., Ltd. Medical Affairs
Outcome results
None listed